ArticleDiscover oncology2026

Distinct cMET inhibitors uncover pharmacological heterogeneity in SHH medulloblastoma cell lines.

Sonia Morlando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.